Gratifii Limited Finalizes Placement of 141.6 Million Shares at AUD 0.04 Each

Capital Raise Structure and Shareholder Approval Details for Gratifii

The issuance of 141.625 million shares by Gratifii Limited forms part of a two-tranche capital raising strategy that received formal shareholder approval at the 13 July 2026 meeting. The second tranche was specifically authorised under Resolution 3, permitting the company to issue and apply for quotation of these securities. This multi-tranche approach aligns with common practices in Australian equity markets to manage liquidity and investor allocation across scheduled releases.

This placement corresponds with a prior Appendix 3B announcement dated 15 May 2026, which outlined the proposed security issuance to the market. This linkage indicates that Gratifii’s management had previously communicated the capital raise framework to investors, with the current quotation application marking the execution of the second phase. The timeline from May announcement to July shareholder approval reflects adherence to ASX procedural requirements for capital management.

Share Pricing and Cash Consideration Information

The 141.625 million shares issued under Tranche 2 were priced at AUD 0.04 each, payable in Australian dollars. This pricing represents the company’s valuation at placement and the cash consideration investors provided per fully paid ordinary share. At this price, the tranche generated approximately AUD 5.665 million in gross capital before expenses, although the announcement does not specify net proceeds or transaction costs.

This cash-based issuance confirms direct funding from investors, distinct from scrip or performance-linked considerations. The use of AUD confirms the transaction’s alignment with Gratifii’s Australian primary listing. The company has not disclosed the net proceeds or the intended use of funds in this update.

Capital Structure After Completion of Tranche 2

Following quotation of the 141.625 million shares, Gratifii’s total quoted ordinary share capital will stand at 682.006 million fully paid shares trading under ASX code GTI. This significant increase reflects a notable expansion of the company’s equity base and shareholder dilution associated with this placement.

In addition to quoted shares, Gratifii holds unquoted securities including options and performance rights with varying exercise prices and expiry dates. These include 2.11 million options expiring 31 December 2026 at AUD 0.30, 8.7 million options expiring 1 January 2029 at AUD 0.10, 3.0 million options expiring 1 June 2028 at AUD 0.17, plus smaller tranches and 4.717 million performance rights. This mix suggests the company uses equity incentives for employees, directors, or advisors.

Pending Securities and Additional Tranches Under Placement Approval

The update confirms further securities remain to be issued to complete the full capital raise outlined in the 15 May 2026 Appendix 3B. Specifically, director shares and additional options will be issued under a separate Appendix 3G notification and are yet to be quoted. This staged issuance allows Gratifii to manage timing and market impact while maintaining transparency with investors.

Details on quantity, pricing, or timing of these pending securities were not disclosed. Investors should anticipate future updates and ASX filings documenting completion of these tranches. The separation between Tranche 2 ordinary shares and director shares suggests coordination of stakeholder interests and regulatory compliance across different security classes.

Market Environment and Investor Insights for GTI

Gratifii’s capital raise occurred amid ongoing equity market activity by Australian small-cap companies seeking growth capital despite market volatility. The process from May announcement through July shareholder approval and issuance reflects typical ASX governance timelines. The AUD 0.04 issue price provides a valuation benchmark for investors assessing this financing round.

The announcement lacks details on Gratifii’s operational performance or strategic plans for the raised capital. Investors should review further disclosures such as investor presentations and annual reports to evaluate potential impacts on shareholder value. The immediate share price response was not disclosed, though market participants may monitor trading following quotation.

Options and Performance Rights Within Gratifii’s Capital Structure

Gratifii’s unquoted securities portfolio demonstrates a layered equity incentive strategy with options ranging from AUD 0.10 to AUD 0.60 exercise prices and expiries from September 2026 to November 2028. The largest option holding is 8.7 million options exercisable at AUD 0.10 expiring 1 January 2029, offering significant upside if share prices rise above this level. The 4.717 million performance rights likely relate to operational or financial milestone-based incentives.

The presence of these unquoted securities signals potential future dilution if exercised. Their varied terms suggest issuance over multiple periods for purposes such as employee retention, director compensation, or advisor incentives. The company has not disclosed vesting conditions or exercise probabilities in this update.

Quotation Application and ASX Compliance Process

Gratifii’s application for quotation of the 141.625 million shares complies with ASX Listing Rules, submitted via Appendix 2A to add these securities to the official list. This confirms the company’s commitment to ASX regulatory requirements and formally notifies the market that these shares are eligible for trading.

The timeline from May announcement, July shareholder approval, to issuance and quotation application by 20 July 2026 demonstrates efficient execution. The quotation application completion is the final step before trading of Tranche 2 shares commences, pending ASX approval.

Shareholder Distribution and Ownership Post-Placement

The update includes a template for reporting shareholder distribution across standard holding brackets, though specific data was not disclosed publicly. This information typically indicates whether the placement was broadly distributed among retail and institutional investors or concentrated among select sophisticated investors. The absence of this data suggests it may be provided in future filings or periodic reports.

Understanding shareholder composition is important for assessing liquidity, voting power, and potential future capital raises. A placement skewed toward institutional investors may indicate strong backing, while broader distribution suggests retail participation. Investors should watch for supplementary disclosures detailing the shareholder register after Tranche 2 settlement.

Capital Raise Timeline and Coordination With Prior Disclosures

Gratifii’s capital raise began with the Appendix 3B announcement on 15 May 2026, outlining the proposed securities issuance. The shareholder meeting on 13 July 2026 provided formal approval, with Resolution 3 authorising the Tranche 2 placement. The issuance and quotation application on 20 July 2026 completes this public capital raise phase.

This timeline reflects Gratifii’s compliance with ASX disclosure and governance standards, providing market notice, securing shareholder approval, executing issuance, and applying for quotation within a defined period. However, the announcement does not specify the strategic use of the AUD 5.665 million gross proceeds, limiting investor insight into capital deployment.